FDA Approves First Alzheimer's Drug
Update: 2025-12-11
Description
Leqembi, the first Alzheimers drug to receive full FDA approval, targets amyloid beta plaques, slowing disease progression. This breakthrough offers hope for millions, with Medicare now covering the cost, making it accessible to more patients.
DNN | The Daily News Now!
The world’s first global local news network.
Every city. Every story. AI powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
